Why medtech firms are putting diabetes tech in consumer devices.
“Abbott CEO Robert Ford has said he expects the consumer devices to contribute to the company’s goal of $10 billion in sales for its Libre business by 2028.” ~ learn more
“Abbott CEO Robert Ford has said he expects the consumer devices to contribute to the company’s goal of $10 billion in sales for its Libre business by 2028.” ~ learn more
In another, more recent, experiment with human hookworm species Necator americanus, researchers found that “lowered HOMA-IR values indicated that people were experiencing considerable improvements in insulin sensitivity – results that were both clinically and statistically significant.” ~ learn more
This article from AARP covers the increasing adoption of this technology for wellness rather than diabetes management. It’s relatively balanced. ~ learn more
This is news worth cheering for! “When students see patients begin to reverse their diabetes, it’s an eye-opener.” ~ learn more
This is a 2014 TEDx talk by aging researcher Nir Barzilai. Almost a decade later, I think the fight against aging is still not generally well-understood and accepted. “Aging is a common risk factor for many diseases, including cancer, diabetes, […]
“Australian scientists have demonstrated a new way to restore insulin production in pancreatic cells, using a drug that’s already approved for use in humans.” | learn more
“This new study carried out by scientists at the University of Connecticut sought to shine new light on the role these zombie cells play in type 2 diabetes, a metabolic condition affecting around 34 million people in the US.” | learn more
“Have you ever heard of the saying “eat your salad first?” The strategy of meal sequencing or eating specific foods in a particular order has been around for years. This tool is very popular in the diabetic world. However, if […]
“A team of biohackers is on a David-versus-Goliath mission to make insulin affordable to an increasing number of diabetics.” | learn more
On the heels of last week’s Peter Attia link, here’s his fleshed out article full of citations. “Some experts suggest CGMs are useless for nondiabetics. I disagree.” For those new to Peter Attia, he’s a practicing physician (MD) focusing on the […]